Did Thomas Tuberville buy Humacyte stock?

Common questions

Did Thomas Tuberville buy Humacyte stock?

Yes. Thomas Tuberville disclosed 7 purchases and 2 sales of Humacyte (HUMA) stock between Jul 25, 2023 and Apr 30, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $35K-$175K and the disclosed sales to $51K-$115K.

How big were Thomas Tuberville's Humacyte trades?

STOCK Act reports give a range for each trade, such as $50K-$100K, never an exact amount. Added together, the disclosed purchases come to $35K-$175K and the disclosed sales to $51K-$115K.

Did Thomas Tuberville make these Humacyte trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Thomas Tuberville still own Humacyte stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Thomas Tuberville report these trades?

The latest filing is dated May 15, 2024. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Secretary of the Senate. Every trade links to the original filing.